Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome

Autoimmunity Reviews

Volumn 6, Issue 2, 2006, Pages 85-88

  Gómez Puerta, José A ^a   Cervera, Ricard ^a   Espinosa, Gerard ^a   Bucciarelli, Silvia ^a   Font, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Obstetric period; Pregnancy; Pregnancy losses; Puerperium

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABORTION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; FETUS MATURITY; HUMAN; HYPERCOAGULABILITY; INFECTION; LUNG EMBOLISM; LUPUS VULGARIS; MICROANGIOPATHY; MULTIPLE ORGAN FAILURE; NEOPLASM; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PUERPERIUM; REVIEW; RISK FACTOR; TERMINAL DISEASE; WITHDRAWAL SYNDROME;

ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PUERPERAL DISORDERS;

EID: 33751322492     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.06.010     Document Type: Review

References (15)

1. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Euro-phospholipid project group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 (2002) 1019-1027
2. Cervera R., and Balasch J. The management of pregnant patients with antiphospholipid syndrome. Lupus 13 (2004) 683-687
3. Branch D.W., and Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 101 (2003) 1333-1344
4. Chakravarty E.F., Nelson L., and Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54 (2006) 899-907
5. Asherson R.A. The catastrophic antiphospholipid syndrome. J Rheumatol 19 (1992) 508-512
6. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Borcoglu A., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195-207
7. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., Petri M.A., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 355-377
8. Brenner B. Haemostatic changes in pregnancy. Thromb Res 114 (2004) 409-414
9. Toglia M.R., and Weg J.G. Venous thromboembolism during pregnancy. N Engl J Med 335 (1996) 108-114
10. Pabinger I., and Grafenhofer H. Thrombosis during pregnancy: risk factors, diagnosis and treatment. Pathophysiol Haemost Thromb 32 (2002) 322-324
11. Heit J.A., Kobbervig C.E., James A.H., Petterson T.M., Bailey K.R., and Melton III L.J. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143 (2005) 697-706
12. Kujovich J.L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 191 (2004) 412-424
13. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. von Villebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic-uremic syndrome. N Engl J Med 339 (1998) 1578-1584
14. Sanchez-Luceros A., Farias C.E., Amaral M.M., Kempfer A.C., Votta R., Marchese C., et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 92 (2004) 1320-1326
15. Asherson R.A., Cervera R., de Groot P.G., Erkan D., Boffa M.C., Piette J.C., et al. Catastrophic antiphospholipid syndrome registry project group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530-534